InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Palmer Pamela P, Directeur Médical. Director active across 2 companies, notably Acelrx Pharmaceuticals INC. Aggregated, 11 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €10k. Activity tracked since 6 February 2022. The latest transaction was filed on 3 March 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Palmer Pamela P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
450 shares@ US$1.3039.8% of flowCommon StockSEC:0001209191-24-004245:0
18,000 shares0Common StockSEC:0001209191-24-004045:0
801 shares@ US$1.1060.2% of flowCommon StockSEC:0001209191-24-003307:0
9,514 shares@ US$1.1743.2% of flowCommon StockSEC:0001209191-23-047348:0
570 shares@ US$1.313.0% of flowCommon StockSEC:0001209191-23-016324:0
1,017 shares@ US$1.686.7% of flowCommon StockSEC:0001209191-23-009131:1
6,125 shares0Common StockSEC:0001209191-23-009131:0
681 shares@ US$2.025.3% of flowCommon StockSEC:0001209191-23-007816:0
7,923 shares@ US$0.406829.1% of flowCommon StockSEC:0001209191-22-016251:0
122,500 shares0Common StockSEC:0001209191-22-009353:0
9,391 shares@ US$0.431235.5% of flowCommon StockSEC:0001209191-22-007635:0
11 of 11 declarations
About Palmer Pamela P
Pamela P. Palmer serves as the Chief Medical Officer at AcelRx Pharmaceuticals Inc. She oversees the medical and clinical initiatives of the company. Her role is essential in ensuring the safety and efficacy of the medical products developed by AcelRx.
